A review of endothelial dysfunction in diabetes: A focus on the contribution of a dysfunctional eNOS

Journal of the American Society of Hypertension

Volumn 4, Issue 3, 2010, Pages 102-115

  Triggle, Chris R ^a   Ding, Hong ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (Qatar)

Author keywords

apoptosis; calpain; cyclooxygenase (COX); Diabetes; endothelial nitric oxide synthase (eNOS); endothelium derived contracting factor (EDCFs); endothelium derived hyperpolarizing factor (EDHF); histone methylation; hyperglycemia; NADPH oxidase; protein kinase C (PKC); store operated Ca2+ entry (SOCE)

Indexed keywords

7 [3 [(4 PHENYLSEMICARBAZIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; ALPHA TOCOPHEROL; ANTIOXIDANT; APAMIN; APOCYNIN; ASCORBIC ACID; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; BETA CAROTENE; BIOPTERIN; CHARYBDOTOXIN; DIHYDROBIOPTERIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; GLUCOSE; HYDROGEN SULFIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INDOMETACIN; INSULIN; METHACHOLINE; NITRIC OXIDE; PLACEBO; PR 11; PROTEASOME INHIBITOR; PROTEIN KINASE C INHIBITOR; RUBOXISTAURIN; STREPTOZOCIN; SULFAPHENAZOLE; TEMPOL; TETRAHYDROBIOPTERIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIOXIDANT ACTIVITY; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CLINICAL TRIAL; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DNA FLANKING REGION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG INHIBITION; DYSLIPIDEMIA; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; FLOW MEASUREMENT; GLUCOSE BLOOD LEVEL; HEART PROTECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERGLYCEMIA; HYPERPHENYLALANINEMIA; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MEDIATOR; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; RABBIT; REVIEW; RISK FACTOR; STREPTOZOCIN DIABETES; VASCULAR DISEASE; VASODILATATION; VITAMIN SUPPLEMENTATION; ENZYMOLOGY; METABOLISM; PHYSIOLOGY; VASCULAR ENDOTHELIUM; VASOCONSTRICTION;

DIABETES MELLITUS; ENDOTHELIUM, VASCULAR; HUMANS; NITRIC OXIDE SYNTHASE TYPE III; VASOCONSTRICTION;

EID: 77954724449     PISSN: 19331711     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jash.2010.02.004     Document Type: Review

References (141)

1. R.F. Furchgott, and J.V. Zawadzki The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine Nature 288 1980 373 376
2. K.L. Andrews, M. Pannirselvam, T.J. Anderson, A.J. Jenkins, C.R. Triggle, and M.A. Hill The vascular endothelium in diabetes: a practical target for drug treatment? Expert Opin Ther Targets 9 2005 101 117
3. M. Félétou, and P.M. Vanhoutte Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture) Am J Physiol Heart Circ Physiol 291 2006 H985 1002
4. C.R. Triggle, A. Howarth, Z.J. Cheng, and H. Ding Twenty-five years since the discovery of endothelium-derived relaxing factor (EDRF): does a dysfunctional endothelium contribute to the development of type 2 diabetes? Can J Physiol Pharmacol 83 2005 681 700
5. J. Xu, and M.H. Zou Molecular insights and therapeutic targets for diabetic endothelial dysfunction Circulation 120 2009 1266 1286
6. T.J. Anderson, A. Uehata, M.D. Gerhard, I.T. Meredith, S. Knab, and D. Delagrange Close relation of endothelial function in the human coronary and peripheral circulations J Am Coll Cardiol 26 1995 1235 1241
7. T.J. Anderson Assessment and treatment of endothelial dysfunction in humans J Am Coll Cardiol 34 1999 631 638
8. S. Verma, and T.J. Anderson Fundamentals of endothelial function for the clinical cardiologist Circulation 105 2002 546 549 (Pubitemid 34123425)
9. J.P. Halcox, W.H. Schenke, G. Zalos, R. Mincemoyer, A. Prasad, and M.A. Waclawiw Prognostic value of coronary vascular endothelial dysfunction Circulation 106 2002 653 658
10. S.M. Grundy, B. Howard, S. Smith Jr., R. Eckel, R. Redberg, and R.O. Bonow Prevention Conference VI: Diabetes and Cardiovascular Disease: Executive Summary: Conference Proceeding for Healthcare Professionals From a Special Writing Group of the American Heart Association Circulation 105 2002 2231 2239
11. H. Kawano, T. Motoyama, O. Hirashima, N. Hirai, Y. Miyao, and T. Sakamoto Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery J Am Coll Cardiol 34 1999 146 154
12. C.R. Triggle The early effects of elevated glucose on endothelial function as a target in the treatment of type 2 diabetes Drugs Today (Barc) 43 2007 815 826
13. D. Brasacchio, J. Okabe, C. Tikellis, A. Balcerczyk, P. George, and E.K. Baker Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-activating epigenetic marks that coexist on the lysine tail Diabetes 58 2009 1229 1236
14. S. Verma, P.E. Szmitko, and T.J. Anderson Endothelial function: ready for prime time? Can J Cardiol 20 2004 1335 1339
15. B. Thorand, J. Baumert, A. Döring, A. Schneider, L. Chambless, and H. Löwel Association of cardiovascular risk factors with markers of endothelial dysfunction in middle-aged men and women. Results from the MONICA/KORA Augsburg Study Thromb Haemost 95 2006 134 141
16. J. Constans, and C. Conri Circulating markers of endothelial function in cardiovascular disease Clin Chim Acta 368 2006 33 47
17. M.I. Cybulsky, and M.A. Gimbrone Jr. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis Science 251 1991 788 791
18. D.S. McLeod, D.J. Lefer, C. Merges, and G.A. Lutty Enhanced expression of intracellular adhesion molecule-1 and P-selectin in the diabetic human retina and choroid Am J Pathol 147 1995 642 653
19. A. Schäfer, N.J. Alp, S. Cai, C.A. Lygate, S. Neubauer, and M. Eigenthaler Reduced vascular NO bioavailability in diabetes increases platelet activation in vivo Arterioscler Thromb Vasc Biol 24 2004 1720 1726
20. H. Duplain, R. Burcelin, C. Sartori, S. Cook, M. Egli, and M. Lepori Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase Circulation 104 2001 342 345
21. G.J. Waldron, H. Ding, F. Lovren, P. Kubes, and C.R. Triggle Acetylcholine-induced relaxation of peripheral arteries isolated from mice lacking endothelial nitric oxide synthase Br J Pharmacol 128 1999 653 658
22. R.D. Rainbow, M.E. Hardy, N.B. Standen, and N.W. Davies Glucose reduces endothelin inhibition of voltage-gated potassium channels in rat arterial smooth muscle cells J Physiol 75 2006 833 844
23. S.V. Straub, H. Girouard, P.E. Doetsch, R.M. Hannah, M.K. Wilkerson, and M.T. Nelson Regulation of intracerebral arteriolar tone by K(v) channels: effects of glucose and PKC Am J Physiol Cell Physiol 297 2009 C788 C796
24. M. Tsutsui, S. Milstien, and Z.S. Katusic Effect of tetrahydrobiopterin on endothelial function in canine middle cerebral arteries Circ Res 79 1996 336 342
25. Z.S. Katusic, and L.V. d'Uscio Tetrahydrobiopterin: mediator of endothelial protection Arterioscler Thromb Vasc Biol 24 2004 397 398
26. A.C. Muntau, W. Röschinger, M. Habich, H. Demmelmair, B. Hoffmann, and C.P. Sommerhoff Tetrahydrobiopterin as an alternative treatment for mild phenylketonuria N Engl J Med 347 2002 2122 2132
27. K.M. Channon Tetrahydrobiopterin: regulator of endothelial nitric oxide synthase in vascular disease Trends Cardiovasc Med 14 2004 323 327
28. M. Pannirselvam, V. Simon, S. Verma, T. Anderson, and C.R. Triggle Chronic oral supplementation with sepiapterin prevents endothelial dysfunction and oxidative stress in small mesenteric arteries from diabetic (db/db) mice Br J Pharmacol 140 2003 701 706
29. T. Heitzer, K. Krohn, S. Albers, and T. Meinertz Tetrahydrobioptern improves endothelium-dependent vasodilation by increasing nitric oxide activity in patients with type II diabetes meliitus Diabetologia 43 2000 1435 1438
30. F. Cosentino, D. Hürlimann, C. Delli Gatti, R. Chenevard, N. Blau, and N.J. Alp Chronic treatment with tetrahydrobiopterin reverses endothelial dysfunction and oxidative stress in hypercholesterolaemia Heart 94 2008 487 492
31. M.I. Worthley, R.S. Kanani, Y.H. Sun, Y. Sun, D.M. Goodhart, and M.J. Curtis Effects of tetrahydrobiopterin on coronary vascular reactivity in atherosclerotic human coronary arteries Cardiovasc Res 76 2007 539 546
32. N.J. Alp, M.A. McAteer, J. Khoo, R.P. Choudhury, and K.M. Channon Increased endothelial tetrahydrobiopterin synthesis by targeted transgenic GTP-cyclohydrolase I overexpression reduces endothelial dysfunction and atherosclerosis in ApoE-knockout mice Arterioscler Thromb Vasc Biol 24 2004 445 450
33. Y. Hattori, N. Nakanishi, and K. Akimoto HMG-CoA reductase inhibitor increases GTP cyclohydrolase I mRNA and tetrahydrobiopterin levels in vascular endothelial cells Arterioscler Vasc Biol 23 2003 176 182
34. S. Cai, J. Khoo, S. Mussa, N.J. Alp, and K.M. Channon Endothelial nitric oxide synthase dysfunction in diabetic mice: importance of tetrahydrobiopterin in eNOS dimerisation Diabetologia 48 2005 1933 1940
35. Y.S. Chatzizisis, A.U. Coskun, M. Jonas, E.R. Edelman, C.L. Feldman, and P.H. Stone Role of endothelial shear stress in the natural history of coronary atherosclerosis and vascular remodeling: molecular, cellular, and vascular behavior J Am Coll Cardiol 49 2007 2379 2393
36. J.P. De Bono, and K.M. Channon Endothelial cell tetrahydrobiopterin: going with the flow Circ Res 101 2007 752 754
37. J.D. Widder, W. Chen, L. Li, S. Dikalov, B. Thöny, K. Hatakeyama, and D.G. Harrison Regulation of tetrahydrobiopterin biosynthesis by shear stress Circ Res 101 2007 830 838
38. H.S. Park, S.M. Lee, J.H. Lee, Y.S. Kim, Y.S. Bae, and J.W. Park Phosphorylation of the leucocyte NADPH oxidase subunit p47(phox) by casein kinase 2: conformation-dependent phosphorylation and modulation of oxidase activity Biochem J 358 2001 783 790
39. M. Pannirselvam, S. Verma, T.J. Anderson, and C.R. Triggle Cellular basis of endothelial dysfunction in small mesenteric arteries from spontaneously diabetic (db/db -/-) mice: role of decreased tetrahydrobiopterin bioavailability Br J Pharmacol 136 2002 255 263
40. E. Stroes, J. Kastelein, F. Cosentino, W. Erkelens, R. Wever, and H. Koomans Tetrahydrobiopterin restores endothelial function in hypercholesterolemia J Clin Invest 99 1997 41 46
41. S. Verma, F. Lovren, A.S. Dumont, K.J. Mather, A. Maitland, and T.M. Kieser Tetrahydrobiopterin improves endothelial function in human saphenous veins J Thorac Cardiovasc Surg 120 2000 668 671
42. T.S. Schmidt, and N.J. Alp Mechanisms for the role of tetrahydrobiopterin in endothelial function and vascular disease Clin Sci (Lond) 113 2007 47 63
43. N.J. Alp, and K.M. Channon Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease Arterioscler Thromb Vasc Biol 24 2004 413 420
44. N. Ihlemann, C. Rask-Madsen, A. Perner, H. Dominguez, T. Hermann, and L. Køber Tetrahydrobiopterin restores endothelial dysfunction induced by an oral glucose challenge in healthy subjects Am J Physiol Heart Circ Physiol 285 2003 H875 H882
45. Z. Bagi, E. Toth, A. Koller, and G. Kaley Microvascular dysfunction after transient high glucose is caused by superoxide-dependent reduction in the bioavailability of NO and BH(4) Am J Physiol Heart Circ Physiol 287 2004 H626 H633
46. T.M. Griffith, A.T. Chaytor, L.M. Bakker, and D.H. Edwards 5-Methyltetrahydrofolate and tetrahydrobiopterin can modulate electrotonically mediated endothelium-dependent vascular relaxation Proc Natl Acad Sci U S A 102 2005 7008 7013
47. M. Aljofan, and H. Ding Oxidative stress and increased eNOS and NADPH oxidase expression in mouse microvessel endothelial cells J Cell Physiol 212 2007 682 689
48. M. Aljofan, and H. Ding High glucose increases expression of cyclooxygenase-2, increases oxidative stress and decreases the generation of nitric oxide in mouse microvessel endothelial cells J Cell Physiol 222 2010 669 675
49. M.J. Crabtree, A.L. Tatham, A.B. Hale, N.J. Alp, and K.M. Channon Critical role for tetrahydrobiopterin recycling by dihydrofolate reductase in regulation of endothelial nitric-oxide synthase coupling: relative importance of the de novo biopterin synthesis versus salvage pathways J Biol Chem 284 2009 28128 28136
50. J. Vásquez-Vivar, P. Martásek, J. Whitsett, J. Joseph, and B. Kalyanaraman The ratio between tetrahydrobiopterin and oxidized tetrahydrobiopterin analogues controls superoxide release from endothelial nitric oxide synthase: an EPR spin trapping study Biochem J 362 2002 733 739
51. J. Vásquez-Vivar, D. Duquaine, J. Whitsett, B. Kalyanaraman, and S. Rajagopalan Altered tetrahydrobiopterin metabolism in atherosclerosis: implications for use of oxidized tetrahydrobiopterin analogues and thiol antioxidants Arterioscler Thromb Vasc Biol 22 2002 1655 1661
52. T. Sugiyama, B.D. Levy, and T. Michel Tetrahydrobiopterin recycling, a key determinant of endothelial nitric-oxide synthase-dependent signaling pathways in cultured vascular endothelial cells J Biol Chem 284 2009 12691 12700
53. M. Takeda, T. Yamashita, M. Shinohara, N. Sasaki, T. Takaya, and K. Nakajima Plasma tetrahydrobiopterin/dihydrobiopterin ratio: a possible marker of endothelial dysfunction Circ J 73 2009 955 962
54. J. Xu, Y. Wu, P. Song, M. Zhang, S. Wang, and M.H. Zou Proteasome-dependent degradation of guanosine 5'-triphosphate cyclohydrolase I causes tetrahydrobiopterin deficiency in diabetes mellitus Circulation 116 2007 944 953
55. M. Brownlee The pathobiology of diabetic complications: a unifying mechanism Diabetes 54 2005 1615 1625
56. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial Lancet 360 2002 23 33
57. G. Groeger, C. Quiney, and T.G. Cotter Hydrogen peroxide as a cell-survival signaling molecule Antioxid Redox Signal 11 2009 2655 2671
58. N.J. Lane A unifying view of ageing and disease: the double-agent theory Theor Biol 225 2003 531 540
59. P. Pacher, J.S. Beckman, and L. Liaudet Nitric oxide and peroxynitrite in health and disease Physiol Rev 87 2007 315 424
60. P. Song, Y. Wu, J. Xu, Z. Xie, Y. Dong, and M. Zhang Reactive nitrogen species induced by hyperglycemia suppresses Akt signaling and triggers apoptosis by upregulating phosphatase PTEN (phosphatase and tensin homologue deleted on chromosome 10) in an LKB1-dependent manner Circulation 116 2007 1585 1595
61. S. Selemidis, C.G. Sobey, K. Wingler, H.H. Schmidt, and G.R. Drummond NADPH oxidases in the vasculature: molecular features, roles in disease and pharmacological inhibition Pharmacol Ther 120 2008 254 291
62. T. Inoguchi, P. Li, F. Umeda, H.Y. Yu, M. Kakimoto, and M. Imamura High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells Diabetes 49 2000 1939 1945
63. J.A. Beckman, A.B. Goldfine, M.B. Gordon, L.A. Garrett, and M.A. Creager Inhibition of protein kinase Cbeta prevents impaired endothelium-dependent vasodilation caused by hyperglycemia in humans Circ Res 90 2002 107 111
64. M. Brownlee Biochemistry and molecular cell biology of diabetic complications Nature 414 2001 813 820
65. X.L. Du, D. Edelstein, S. Dimmeler, Q. Ju, C. Sui, and M. Brownlee Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site J Clin Invest 108 2001 1341 1348
66. C. Quijano, L. Castro, G. Peluffo, V. Valez, and R. Radi Enhanced mitochondrial superoxide in hyperglycemic endothelial cells: direct measurements and formation of hydrogen peroxide and peroxynitrite Am J Physiol Heart Circ Physiol 293 2007 H3404 H3414
67. F. Cosentino, M. Eto, P. De Paolis, B. van der Loo, M. Bachschmid, and V. Ullrich High glucose causes upregulation of cyclooxygenase-2 and alters prostanoid profile in human endothelial cells: role of protein kinase C and reactive oxygen species Circulation 107 2003 1017 1023
68. N. Shanmugam, I.T. Todorov, I. Nair, K. Omori, M.A. Reddy, and R. Natarajan Increased expression of cyclooxygenase-2 in human pancreatic islets treated with high glucose or ligands of the advanced glycation endproduct-specific receptor (AGER), and in islets from diabetic mice Diabetologia 49 2006 100 107
69. D. Bulut, S. Liaghat, C. Hanefeld, R. Koll, T. Miebach, and A. Mügge Selective cyclo-oxygenase-2 inhibition with parecoxib acutely impairs endothelium-dependent vasodilatation in patients with essential hypertension J Hypertens 21 2003 1663 1667
70. T. Szerafin, N. Erdei, T. Fülöp, E.T. Pasztor, I. Edes, and A. Koller Increased cyclooxygenase-2 expression and prostaglandin-mediated dilation in coronary arterioles of patients with diabetes mellitus Circ Res 99 2006 e12 e17
71. P.M. Vanhoutte Endothelium and control of vascular function. State of the Art lecture Hypertension 13 1998 658 667
72. R.W. Tsien, and R.Y. Tsien Calcium channels, stores, and oscillations Annu Rev Cell Biol 6 1990 715 760
73. A.B. Parekh, and R. Penner Store depletion and calcium influx Physiol Rev 77 1997 901 930
74. B. Nilius, F. Viana, and G. Droogmans Ion channels in vascular endothelium Annu Rev Physiol 59 1997 145 170
75. J.Z. Sheng, D. Wang, and A.P. Braun DAF-FM (4-amino-5-methylamino-2',7'- difluorofluorescein) diacetate detects impairment of agonist-stimulated nitric oxide synthesis by elevated glucose in human vascular endothelial cells: reversal by vitamin C and L-sepiapterin J Pharmacol Exp Ther 315 2005 931 940
76. S. Tamareille, O. Mignen, T. Capiod, C. Rucker-Martin, and D. Feuvray High glucose-induced apoptosis through store-operated calcium entry and calcineurin in human umbilical vein endothelial cells Cell Calcium 39 2006 47 55
77. Y. Li, Y. Li, Q. Feng, M. Arnold, and T. Peng Calpain activation contributes to hyperglycaemia-induced apoptosis in cardiomyocytes Cardiovasc Res 84 2009 100 110
78. T.J. Stalker, Y. Gong, and R. Scalia The calcium-dependent protease calpain causes endothelial dysfunction in type 2 diabetes Diabetes 54 2005 1132 1140
79. S. Bréchard, and E.J. Tschirhart Regulation of superoxide production in neutrophils: role of calcium influx J Leukoc Biol 84 2008 1223 1237
80. N. Bishara, and H. Ding Glucose enhances expression of TRPC and Ca entry in endothelial cells Am J Physiol Heart Circ Physiol 298 2010 H171 H178
81. B. Kumar, K. Dreja, S.S. Shah, A. Cheong, S.Z. Xu, and P. Sukumar Upregulated TRPC1 channel in vascular injury in vivo and its role in human neointimal hyperplasia Circ Res 98 2006 557 563
82. C. van Breemen, D. Poburko, and E.B. Okon TRP proteins: a new dimension in the treatment of occlusive vascular disease Circ Res 98 2006 446 447
83. I.F. Abdullaev, J.M. Bisaillon, M. Potier, J.C. Gonzalez, R.K. Motiani, and M. Trebak Stim1 and Orai1 mediate CRAC currents and store-operated calcium entry important for endothelial cell proliferation Circ Res 103 2008 1289 1299
84. S.F. Pedersen, G. Owsianik, and N. Nilius TRP channels: an overview Cell Calcium 38 2005 233 252
85. T.M. Moore, G.H. Brough, P. Babal, J.J. Kelly, M. Li, and T. Stevens Store-operated calcium entry promotes shape change in pulmonary endothelial cells expressing Trp1 Am J Physiol 275 1998 L574 L582
86. M. Freichel, S.H. Suh, A. Pfeifer, U. Schweig, C. Trost, and P. Weissgerber Lack of an endothelial store-operated Ca2+ current impairs agonist-dependent vasorelaxation in TRP4-/- mice Nat Cell Biol 3 2001 121 127
87. G.N. Huang, W. Zeng, J.Y. Kim, J.P. Yuan, L. Han, and S. Muallem STIM1 carboxyl-terminus activates native SOC, I(crac) and TRPC1 channels Nat Cell Biol 8 2006 1003 1010
88. H.L. Ong, K.T. Cheng, X. Liu, B.C. Bandyopadhyay, B.C. Paria, and J. Soboloff Dynamic assembly of TRPC1-STIM1-Orai1 ternary complex is involved in store-operated calcium influx. Evidence for similarities in store-operated and calcium release-activated calcium channel components J Biol Chem 282 2007 9105 9116
89. L. Luksha, S. Agewall, and K. Kublickiene Endothelium-derived hyperpolarizing factor in vascular physiology and cardiovascular disease Atherosclerosis 202 2009 330 344
90. S.L. Sandow, R.E. Haddock, C.E. Hill, P.S. Chadha, P.M. Kerr, and D.G. Welsh What's where and why at a vascular myoendothelial microdomain signalling complex Clin Exp Pharmacol Physiol 36 2009 67 76
91. J.J. McGuire, H. Ding, and C.R. Triggle Endothelium-derived relaxing factors: a focus on endothelium-derived hyperpolarizing factor(s) Can J Physiol Pharmacol 79 2001 443 470
92. R. Busse, G. Edwards, M. Félétou, I. Fleming, P.M. Vanhoutte, and A.H. Weston EDHF: bringing the concepts together Trends Pharmacol Sci 23 2002 374 380
93. S.L. Sandow, C.B. Neylon, M.X. Chen, and C.J. Garland Spatial separation of endothelial small- and intermediate-conductance calcium-activated potassium channels (K(Ca)) and connexins: possible relationship to vasodilator function? J Anat 209 2006 689 698
94. W.B. Campbell, and J.R. Falck Arachidonic acid metabolites as endothelium-derived hyperpolarizing factors Hypertension 49 2007 590 596
95. M. Félétou, and P.M. Vanhoutte Endothelium-dependent hyperpolarizations: past beliefs and present facts Ann Med 39 2007 495 516
96. M. Félétou, and P.M. Vanhoutte EDHF: an update Clin Sci (Lond) 117 2009 139 155
97. O. Khatsenko Interactions between nitric oxide and cytochrome P-450 in the liver Biochemistry (Mosc) 63 1998 833 839
98. M. Pannirselvam, H. Ding, T.J. Anderson, and C.R. Triggle Pharmacological characteristics of endothelium-derived hyperpolarizing factor-mediated relaxation of small mesenteric arteries from db/db mice Eur J Pharmacol 551 2006 98 107
99. S. Krummen, J.R. Falck, and E. Thorin Two distinct pathways account for EDHF-dependent dilatation in the gracilis artery of dyslipidaemic hApoB+/+ mice Br J Pharmacol 145 2005 264 270
100. S. Taddei, D. Versari, A. Cipriano, L. Ghiadoni, F. Galetta, and F. Franzoni Identification of a cytochrome P450 2C9-derived endothelium-derived hyperpolarizing factor in essential hypertensive patients J Am Coll Cardiol 48 2006 508 515
101. S. Fichtlscherer, S. Dimmeler, S. Breuer, R. Busse, A.M. Zeiher, and I. Fleming Inhibition of cytochrome P450 2C9 improves endothelium-dependent, nitric oxide-mediated vasodilatation in patients with coronary artery disease Circulation 109 2004 178 183
102. S. Selemidis, and T.M. Cocks Endothelium-dependent hyperpolarization as a remote anti-atherogenic mechanism Trends Pharmacol Sci 23 2002 213 220
103. F. Krötz, T. Riexinger, M.A. Buerkle, K. Nithipatikom, T. Gloe, and H.Y. Sohn Membrane-potential-dependent inhibition of platelet adhesion to endothelial cells by epoxyeicosatrienoic acids Arterioscler Thromb Vasc Biol 24 2004 595 600
104. F. Krötz, N. Hellwig, M.A. Bürkle, S. Lehrer, T. Riexinger, and H. Mannell A sulfaphenazole-sensitive EDHF opposes platelet-endothelium interactions in vitro and in the hamster microcirculation in vivo Cardiovasc Res 85 2010 542 550
105. C.E. Chadjichristos, K.E. Scheckenbach, T.A. van Veen, M.Z. Richani Sarieddine, and C. de Wit Endothelial-specific deletion of connexin40 promotes atherosclerosis by increasing CD73-dependent leukocyte adhesion Circulation 121 2010 123 131
106. H. Ding, M. Hashem, W.B. Wiehler, W. Lau, J. Martin, and J. Reid Endothelial dysfunction in the streptozotocin-induced diabetic apoE-deficient mouse Br J Pharmacol 146 2005 1110 1118
107. E.J. Young, M.A. Hill, W.B. Wiehler, C.R. Triggle, and J.J. Reid Reduced EDHF responses and connexin activity in mesenteric arteries from the insulin-resistant obese Zucker rat Diabetologia 51 2008 872 881
108. I. Grgic, B.P. Kaistha, J. Hoyer, and R. Köhler Endothelial Ca+-activated K+ channels in normal and impaired EDHF-dilator responses - relevance to cardiovascular pathologies and drug discovery Br J Pharmacol 157 2009 509 526
109. J. Bellien, J. Favre, M. Iacob, J. Gao, C. Thuillez, and V. Richard Arterial stiffness is regulated by nitric oxide and endothelium-derived hyperpolarizing factor during changes in blood flow in humans Hypertension January 18, 2010 [Epub ahead of print]
110. G. Yang, L. Wu, B. Jiang, W. Yang, J. Qi, and K. Cao H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase Science 322 2008 587 590
111. M.Y. Ali, C.Y. Ping, Y.Y. Mok, L. Ling, M. Whiteman, and M. Bhatia Regulation of vascular nitric oxide in vitro and in vivo; a new role for endogenous hydrogen sulphide? Br J Pharmacol 149 2006 625 634
112. E.S. Ng, Z.J. Cheng, A. Ellis, H. Ding, Y. Jiang, and Y. Li Nitrosothiol stores in vascular tissue: modulation by ultraviolet light, acetylcholine and ionomycin Eur J Pharmacol 560 2007 183 192
113. W. Zhao, J. Zhang, Y. Lu, and R. Wang The vasorelaxant effect of H2S as a novel endogenous gaseous KATP channel opener EMBO J 20 2001 6008 6016
114. V. Brancaleone, F. Roviezzo, V. Vellecco, L. De Gruttola, M. Bucci, and G. Cirino Biosynthesis of H2S is impaired in non-obese diabetic (NOD) mice Br J Pharmacol 155 2008 673 680
115. Y. Wang, X. Zhao, H. Jin, H. Wei, W. Li, and D. Bu Role of hydrogen sulfide in the development of atherosclerotic lesions in apolipoprotein E knockout mice Arterioscler Thromb Vasc Biol 29 2009 173 179
116. P.M. Vanhoutte, M. Félétou, and S. Taddei Endothelium-dependent contractions in hypertension Br J Pharmacol 144 2005 449 458
117. E.H. Tang, and P.M. Vanhoutte Prostanoids and reactive oxygen species: team players in endothelium-dependent contractions Pharmacol Ther 122 2009 140 149
118. P.M. Vanhoutte, and E.H. Tang Endothelium-dependent contractions: when a good guy turns bad! J Physiol 586 2008 5295 5304
119. M. Félétou, T.J. Verbeuren, and P.M. Vanhoutte Endothelium-dependent contractions in SHR: a tale of prostanoid TP and IP receptors Br J Pharmacol 156 2009 563 574
120. T. Traupe, M. Lang, W. Goettsch, K. Münter, H. Morawietz, and W. Vetter Obesity increases prostanoid mediated vasoconstriction and vascular thromboxane receptor gene expression J Hypertens 20 2002 2239 2245
121. Y. Shi, and P.M. Vanhoutte Oxidative stress and COX cause hyper-responsiveness in vascular smooth muscle of the femoral artery from diabetic rats Br J Pharmacol 154 2008 639 651
122. M. Pannirselvam, W.B. Wiehler, T. Anderson, and C.R. Triggle Enhanced vascular reactivity of small mesenteric arteries from diabetic mice is associated with enhanced oxidative stress and cyclooxygenase products Br J Pharmacol 144 2005 953 960
123. Z.J. Cheng, Y.F. Jiang, H. Ding, D. Severson, and C.R. Triggle Vascular dysfunction in type 2 diabetic TallyHo mice: role for an increase in the contribution of PGH2/TxA2 receptor activation and cytochrome p450 products Can J Physiol Pharmacol 85 2007 404 412
124. C. Boulanger, and T.F. Lüscher Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide J Clin Invest 85 1990 587 590
125. P.M. Vanhoutte Say NO to ET J Auton Nerv Syst 8 2000 271 277
126. C. Cardillo, U. Campia, M.B. Bryant, and J.A. Panza Increased activity of endogenous endothelin in patients with type II diabetes mellitus Circulation 106 2002 1783 1787
127. S. Verma, F. Lovren, A.S. Dumont, K.J. Mather, A. Maitland, and T.M. Kieser Endothelin receptor blockade improves endothelial function in human internal mammary arteries Cardiovasc Res 49 2001 146 151
128. A.S. Dumont, F. Lovren, J.H. McNeill, G.R. Sutherland, C.R. Triggle, and T.J. Anderson Augmentation of endothelial function by endothelin antagonism in human saphenous vein conduits J Neurosurg 94 2001 281 286
129. D. Rizzoni, E. Porteri, D. Guelfi, M.L. Muiesan, U. Valentini, and A. Cimino Structural alterations in subcutaneous small arteries of normotensive and hypertensive patients with non-insulin-dependent diabetes mellitus Circulation 103 2001 1238 1244 (Pubitemid 32221346)
130. D. Rizzoni, E. Porteri, D. Guelfi, M.L. Muiesan, A. Piccoli, and U. Valentini Endothelial dysfunction in small resistance arteries of patients with non-insulin-dependent diabetes mellitus J Hypertens 19 2001 913 919
131. C. Cardillo, U. Campia, C.M. Kilcoyne, M.B. Bryant, and J.A. Panza Improved endothelium-dependent vasodilation after blockade of endothelin receptors in patients with essential hypertension Circulation 105 2002 452 456
132. B. Moazed, D. Quest, and V. Gopalakrishnan Des-acyl ghrelin fragments evoke endothelium-dependent vasodilatation of rat mesenteric vascular bed via activation of potassium channels Eur J Pharmacol 604 2009 79 86
133. U.A. Shinde, K.M. Desai, C. Yu, and V. Gopalakrishnan Nitric oxide synthase inhibition exaggerates the hypotensive response to ghrelin: role of calcium-activated potassium channels J Hypertens 23 2005 779 784
134. M. Tesauro, F. Schinzari, V. Rovella, N. Di Daniele, D. Lauro, N. Mores, and A. Veneziani Ghrelin restores the endothelin 1/nitric oxide balance in patients with obesity-related metabolic syndrome Hypertension 54 2009 995 1000
135. L. Engerman, and T.S. Kern Progression of incipient diabetic retinopathy during good glycemic control Diabetes 36 1987 808 812
136. P. Fioretto, S.M. Mauer, R.W. Bilous, F.C. Goetz, D.E. Sutherland, and M.W. Steffes Effects of pancreas transplantation on glomerular structure in insulin-dependent diabetic patients with their own kidneys Lancet 342 1993 1193 1196
137. P. Fioretto, M.W. Steffes, D.E. Sutherland, F.C. Goetz, and M. Mauer Reversal of lesions of diabetic nephropathy after pancreas transplantation N Engl J Med 339 1998 69 75 (Pubitemid 28304880)
138. A. Ceriello, K. Esposito, M. Ihnat, J. Thorpe, and D. Giugliano Long-term glycemic control influences the long-lasting effect of hyperglycemia on endothelial function in type 1 diabetes J Clin Endocrinol Metab 94 2009 2751 2756
139. M. Shinohara, P.J. Thornalley, I. Giardino, P. Beisswenger, S.R. Thorpe, and J. Onorato Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis J Clin Invest 101 1998 1142 1147
140. E. Linden, W. Cai, J.C. He, C. Xue, Z. Li, and J. Winston Endothelial dysfunction in patients with chronic kidney disease results from advanced glycation end products (AGE)-mediated inhibition of endothelial nitric oxide synthase through RAGE activation Clin J Am Soc Nephrol 3 2008 691 698
141. A. El-Osta, D. Brasacchio, D. Yao, A. Pocai, P.L. Jones, and R.G. Roeder Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia J Exp Med 205 2008 2409 2417